Algae Dynamics Corp. (ADYNF) Collaborates with University

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
1,150
Algae Dynamics Corp. (ADYNF) Collaborates with University of Western Ontario

- Research finds that higher levels of the brain chemical GABA can reverse negative effects such as schizophrenia and depression
- Professor Steven Laviolette, who spearheaded the study, hopes that GABA-increasing cannabinoid compounds developed with industrial partners from this research could lead to clinical trials “in the next few years”
- Algae Dynamics Corp. has signed a collaborative agreement with the University of Western Ontario, giving the company the patent rights to any drugs developed as a result of research

Algae Dynamics Corp. (OTCQB: ADYNF) is in a collaboration agreement with the University of Western Ontario (now rebranded as Western University), which is making international news with its recent study in Nature Scientific Reports (http://nnw.fm/aJ7Oh). The study found that the negative effects on the adolescent brain from chronic use of tetrahydrocannabinol (THC)-rich marijuana can be reversed by using compounds which increase the amounts of GABA, a chemical and neurotransmitter in the brain.

The article in Nature Scientific Reports is titled “Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.” The results have been globally reported by Global News, CBC of London, CTV News and UPI.

“What this could mean is that if you are going to be using marijuana, in a recreational or medicinal way, you can potentially combine it with compounds that boost GABA to block the negative effects of THC,” Professor Steven Laviolette of Western University’s Schulich School of Medicine and Dentistry told UPI (http://nnw.fm/yKuH2). Laviolette spearheaded the research study.

Laviolette has focused on the impact of nicotine and opiates and the neurobiology of addiction. He is studying the interface of neurobiology, psychology and emotion by using an integrative combination of behavioral neuropharmacology and vivo neuronal electrophysiology.

THC exposure reduced the GABA in the brain, the study found. GABA regulates hyperactivity in the brain and has been associated with disorders such as schizophrenia. Negative effects developed later in adulthood from use of marijuana with THC include anxiety, depression and schizophrenia. Drugs that increase the amount of GABA could then reverse the impact of THC and eliminate the schizophrenia-linked symptoms, the research found.

“We actually went in, and tried to restore the GABA system by activating GABA receptors directly in the prefrontal cortex,” Laviolette said on the Andrew Lawton radio show in Canada (http://nnw.fm/07Snd). “To our amazement, we found that this reversed those schizophrenia-like symptoms,” he added in an interview with CBC London. He explained that the reversal process can still remain effective many years after the exposure.

“What is important about this study is that not only have we developed a specific mechanism in the prefrontal mechanism for some of the mental health risks associated with adolescent marijuana use,” Laviolette told UPI. “But we have also identified a mechanism to reverse those risks.”

More research is needed to learn if boosting GABA levels would have the same results in humans as in rats, but Laviolette said that, to those people with mental health problems, there may be new hope. Laviolette told CTV News, “I think this is really a promising lead in terms of the potential of developing much safer versions of cannabinoid type drugs.”

Global News added that the next step is combining cannabinoid chemicals with compounds to boost the GABA system. The goal would be to determine better treatments for a range of other mental health disorders, such as anxiety, depression and addiction.

Laviolette, interviewed on the Lawton Show, explained that there is a need now to “dig further” into this research. The result could be more molecular pathways in the future to formulate pharmaceutical compounds with industrial partners, including the process of conducting clinical trials within the next few years. Compounds using cannabinoids may be developed in the future, he said. Cannabidiol can actually have the opposite effect of THC — negating the impact of THC.

He told Lawton that some ‘black market’ marijuana may contain up to 70% THC. THC can also increase dependency levels, he said. The reversal process may suggest larger treatment issues for schizophrenia, regardless of marijuana or THC use.

Forbes reported (http://nnw.fm/0OmnV) that another study found that chronic cannabis use can result in blunted stress reactivity. That study observed 40 cannabis users and 42 non-users to complete the stress or no-stress conditions of the Maastricht Acute Stress Test (MAST). Saliva samples and cannabis cravings and withdrawal were measured, as part of the study. Results indicated a link between higher stress ratings in non-users. In contrast, chronic cannabis users exhibited blunted stress reactivity, it said. Forbes inferred that marijuana compounds can reduce stress without the dependency of prescription medications.

While preliminary, Forbes explained, the study suggests that marijuana compounds may eventually be used to provide anxiety relief with decreased dependency, fewer side effects and reduced overdose potential.

ADYNF is engaged in the development of products and pharmaceuticals that use cannabis, hemp and algae oils. The development stage company is based in Canada and publicly traded in the U.S. The company has signed a collaboration agreement with the University of Western Ontario, enabling the firm to retain the rights to patents developed in conjunction with the school. Western University is focused on the areas of depression, post-traumatic stress disorder, anxiety and schizophrenia.

According to an ADYNF corporate presentation (http://nnw.fm/HNa1I), the company is building its intellectual property portfolio in the pharmaceutical field. Its goal is to develop value-added products, supported by strong science and clinical trials, combining the benefits of algae and cannabis oils to enhance efficacy in a unique and patented way.

For more information, visit the company’s website at www.AlgaeDynamics.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

CanaQuest Medical Corporation (CANQF) Stock Research Links

CANQF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 105

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 69

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 73

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 107

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 119

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 93

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Mauna Kea Technologies Advances AI Integration in Endomicroscopy

Updated Category News Views 512

Mauna Kea Technologies and its Innovative AI Patent Mauna Kea Technologies, the proud inventor of Cellvizio®, a revolutionary platform that blends probe and needle-based confocal laser endomicroscopy (p/nCLE), has taken a significant step forward in the realm of artificial intelligence in medical diagnostic procedures. Recently, the company announced the granting of a...

Continue Reading
Hot Chili Limited Secures Approval for La Verde Expansion Drilling

Updated Category News Views 168

Hot Chili Limited's Significant Progress at La Verde Hot Chili Limited (OTCQX: HHLKF) has obtained key regulatory approval to enhance the drill coverage of its La Verde copper-gold discovery. This exciting development comes as the company aims to broaden exploration activities in an area strategically important to its operations. Understanding the La Verde Project The La...

Continue Reading
Investors on High Alert as Lithium Faces Growing Demand Challenges

Updated Category News Views 261

The Lithium Debate: Rising Tensions at COP30 At the recent climate discussions, the dialogue took an unexpected turn, raising eyebrows among investors in various clean-tech sectors. For the first time in thirty years of United Nations climate negotiations, serious concerns emerged regarding the social and environmental risks associated with lithium mining, which is...

Continue Reading
Edible Garden Expands USDA Organic Herb Line in New Markets

Updated Category News Views 71

Introducing Edible Garden's Organic Product Line Edible Garden AG Incorporated has been making headlines as a leader in controlled environment agriculture (CEA). Recently, they launched their USDA Organic herb product line at Green’s Natural Foods and The Extra Supermarket, which is a significant step in their mission to provide sustainably grown and organic produce....

Continue Reading
Growth Surge: The Value of $100 Investment in Riot Platforms

Updated Category News Views 148

Understanding the Rise of Riot Platforms Investors seeking substantial growth often look to companies like Riot Platforms (NASDAQ: RIOT), which has demonstrated impressive performance over the past five years. With a remarkable annualized return of 46.95%, Riot has outpaced the market by over 34.28%. This consistent growth contributes to a current market capitalization of...

Continue Reading